Institutions / Pavaki Capital Management LLC
Pavaki Capital Management LLC
CIK 2143027 · Institution · as of Jun 30, 2026
Portfolio value
$175.52M
Positions
132
As of
Jun 30, 2026
Portfolio trend
Portfolio value
$175.52M+23.3%Positions
132+9.1%Top holdings
Jun 30, 2026View all 132 →
| Company | Value | % of portfolio |
|---|---|---|
| Chevron Corp | $16.08M | 9.2% |
| Milestone Pharmaceuticals Inc. | $12.15M | 6.9% |
| Intuit Inc. | $10.07M | 5.7% |
| Qualcomm INC/DE | $9.05M | 5.2% |
| Barrick Mng Corp | $8.14M | 4.6% |
| Textron Inc | $7.73M | 4.4% |
| Regeneron Pharmaceuticals, Inc. | $6.17M | 3.5% |
| NVIDIA Corp | $5.20M | 3.0% |
| Arcutis Biotherapeutics, Inc. | $4.90M | 2.8% |
| ARS Pharmaceuticals, Inc. | $4.64M | 2.6% |
| Micron Technology Inc | $4.62M | 2.6% |
| B2GOLD Corp | $4.42M | 2.5% |
| Ligand Pharmaceuticals Inc | $3.51M | 2.0% |
| Centerra Gold Inc | $3.12M | 1.8% |
| Newmont Corp | $3.04M | 1.7% |
| Slb LIMITED/NV | $2.84M | 1.6% |
| Harmony Biosciences Holdings Inc | $2.66M | 1.5% |
| Royalty Pharma PLC Shs | $2.47M | 1.4% |
| Advanced Micro Devices Inc | $2.32M | 1.3% |
| Newamsterdam Pharma Company Ordinary | $2.26M | 1.3% |
| Ssr Mining Inc.SSRM | $2.12M | 1.2% |
| Paramount Skydance CorpPSKY | $2.06M | 1.2% |
| Douglas Elliman Inc.DOUG | $1.81M | 1.0% |
| iShares Inc MSCI Singpor | $1.78M | 1.0% |
| Bio-Rad Laboratories, Inc. | $1.76M | 1.0% |
Activity
Jun 30, 2026View full history →
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Add | Chevron Corp | $15.00M | +73K +3625.00% | 74,500 8.78% of portfolio | medium |
| Q2 2026 as of | Trim | Intel Corp | $-13.40M | -96K -96.00% | 4,000 0.32% of portfolio | medium |
| Q2 2026 as of | New | Intuit Inc. | $10.07M | +39K | 38,600 5.74% of portfolio | medium |
| Q2 2026 as of | New | Qualcomm INC/DE | $9.05M | +49K | 49,000 5.16% of portfolio | medium |
| Q1 2026 as of | Trim | Regeneron Pharmaceuticals, Inc. | $-8.89M | -12K -59.28% | 7,900 3.48% of portfolio | medium |
| Q2 2026 as of | Trim | Walt Disney Co | $-5.78M | -60K -98.36% | 1,000 0.05% of portfolio | medium |
| Q1 2026 as of | Trim | ARS Pharmaceuticals, Inc. | $-4.78M | -596K -50.84% | 576,200 2.64% of portfolio | low |
| Q2 2026 as of | New | Micron Technology Inc | $4.62M | +4K | 4,000 2.63% of portfolio | low |
| Q2 2026 as of | Add | Textron Inc | $3.82M | +42K +97.42% | 84,300 4.41% of portfolio | low |
| Q2 2026 as of | Add | Chevron Corp | $3.73M | +23K +30.20% | 97,000 9.16% of portfolio | low |